To amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization and claims denial under Medicare Advantage plans.
Summary
HR 10394, introduced September 15, 2026, in the 119th Congress, would amend the Social Security Act to establish prior authorization and claims denial requirements for Medicare Advantage plans. The bill is in early legislative stages, referred to the House Ways and Means and Energy and Commerce Committees. No funding is authorized, and no market-moving impact is expected in the near term. The primary affected sector is Healthcare, with potential implications for managed care organizations and healthcare providers, though the bill's procedural status limits direct market effects.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR 10394 is an early-stage bill with no funding authorization and no immediate market impact.
- 2.The bill targets Medicare Advantage prior authorization and claims denial practices, affecting the Healthcare sector.
- 3.No tickers meet the confidence threshold due to the bill's procedural status and lack of direct company impact.
- 4.Investors should watch committee actions for potential amendments that could clarify the bill's scope.
Market Implications
The bill's introduction is unlikely to move markets given its early legislative stage. If it advances, managed care organizations (e.g., UNH, CVS, HUM) could face increased compliance costs, but any impact is speculative until the bill's provisions are finalized. Healthcare providers (e.g., HCA, CYH) might benefit from reduced claims denials, but this is also premature. No real market data is available to cite price movements, so investors should rely on legislative tracking rather than trading on this news.
Full Analysis
HR 10394, titled 'To amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization and claims denial under Medicare Advantage plans,' was introduced in the House on September 15, 2026, by Rep. Greg Landsman (D-OH-1). It has been referred to the House Ways and Means and Energy and Commerce Committees. The bill is in its earliest stage—no committee hearings, markup, or floor votes have occurred. As an authorization bill, it does not appropriate funds; it would set policy requirements for Medicare Advantage plans if enacted. The legislative path ahead includes committee consideration, potential amendments, floor debate, Senate action, and presidential signature or veto. Given the early stage and the 119th Congress's timeline (2025–2027), enactment is uncertain and not imminent. The bill's provisions target prior authorization and claims denial practices, which are operational aspects of Medicare Advantage plans. If enacted, it could increase administrative burdens and compliance costs for insurers, potentially affecting their profitability. However, with no real market data provided and the bill's procedural status, no specific stock price movements can be cited. The affected sector is Healthcare, with primary exposure to managed care organizations and secondary exposure to healthcare providers who would benefit from reduced claims denials. The bill does not directly name any company, so ticker-level impacts are speculative at this stage. The causal chain from bill to company impact is weak: the bill is early-stage, and its provisions are not yet defined in detail. Therefore, no tickers meet the confidence threshold for inclusion. The convergence analysis found no related candidates in the provided data, so the convergence array is empty. In summary, HR 10394 is a procedural healthcare bill with no near-term market impact, and investors should monitor its progress through committee for any substantive changes.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MINNESOTA DEPARTMENT OF HUMAN SERVICES: $11.3B Department of Health and Human Services Grant
STATE OF RHODE ISLAND DEPARTMENT OF ADMINISTRATION: $2.8B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CALIFORNIA: $1.5B Department of Health and Human Services Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.7B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.6B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →